RB1 and hepatocellular carcinoma: Specifically, progesterone has been shown to increase hepatic lipid content and lipid levels through PR-B-mediated lipogenesis (Jeong et al., 2024), a process that can contribute to non-alcoholic fatty liver disease (NAFLD) and its progression to HCC.